Skip to main content
. Author manuscript; available in PMC: 2020 Jan 24.
Published in final edited form as: J Med Chem. 2018 Dec 10;62(2):448–466. doi: 10.1021/acs.jmedchem.8b00909

Figure 14.

Figure 14.

Pharmacodynamic (PD) analysis of MDM2, p53, p21 and PARP cleavage protein levels by western blotting after a single dose of MD-224 administered in the RS4;11 xenograft mouse model. A single dose of MD-224 (25 mg/kg, IV) effectively induces MDM2 degradation, p53 activation and PAPR cleavage in the xenograft RS4;11 tumors.